[ MICHAEL J. FOX FOUNDATION | RESEARCH FUNDING ]
Event details
| Date | 27.09.2017 |
| Category | Call for proposal |
Aim: The ultimate aim of the Michael J. Fox Foundation is to “eliminate Parkinson’s disease in our lifetime”. Their funding strategy strongly emphasizes translational and clinical research, and to this end, they offer support in three broad categories:
Funding: Budgets set by sub-category: target advancement (100,000 USD per project); therapeutic development (100,000-500,00 USD for pre-clinical projects, negotiable for clinical projects); improved biomarkers (4 million USD for all projects; no budget limit)
Duration: Target advancement projects have a 1-year duration; others do not have stated limits, but must provide a timeline.
Pre-proposal Deadline: 27 September 2017
Full proposals Solicited (invitation only): December 2017
Full proposal Deadline (invitation only): 23 January 2018
Anticipated funding: May 2018
Further information
- Target advancement: Novel or established PD-relevant targets
- Therapeutic development: Pre-clinical and clinical avenues
- Improved biomarkers and outcome measures: Development or optimization
Funding: Budgets set by sub-category: target advancement (100,000 USD per project); therapeutic development (100,000-500,00 USD for pre-clinical projects, negotiable for clinical projects); improved biomarkers (4 million USD for all projects; no budget limit)
Duration: Target advancement projects have a 1-year duration; others do not have stated limits, but must provide a timeline.
Pre-proposal Deadline: 27 September 2017
Full proposals Solicited (invitation only): December 2017
Full proposal Deadline (invitation only): 23 January 2018
Anticipated funding: May 2018
Further information
- Webinar available for more information: 7 September 2017 7
- Please check the webpage for all details and application documents
- Contact the Research Office ([email protected])
Practical information
- General public
- Free